Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Veronica Conca

15PUBLICATIONS
94CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumoursMolecular targetsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

Sort by Publication Date:
|Jun 04, 2026
Reply to: "Understanding the Contribution of Anti-EGFR Reinduction to Overall Survival in TRIPLETE Study" and "TRIPLETE But Incomplete? Accounting for Post-Progression Therapy When Interpreting Overall Survival".

|Apr 13, 2026
Circulating tumor DNA dynamics in patients with liver-limited metastatic colorectal cancer resected after first-line systemic treatment.

Roberto Moretto, Vittorio Studiale, Seung Won Hyun

|Jan 08, 2026
Upfront Modified FOLFOXIRI Plus Panitumumab for <i>RAS/BRAF</i> Wild-Type Metastatic Colorectal Cancer: Final Results of the Phase III TRIPLETE Study.

Veronica Conca, Daniele Rossini, Carlotta Antoniotti

|Apr 18, 2025
Exploring the Prognostic and Predictive Impact of Genomic Loss of Heterozygosity and Homologous Recombination Deficiency Alterations in Patients With Metastatic Colorectal Cancer.

Roberto Moretto, Marco Maria Germani, Martina Carullo

|Jun 12, 2024
Upfront Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Bevacizumab With or Without Atezolizumab for Patients With Metastatic Colorectal Cancer: Updated and Overall Survival Results of the ATEZOTRIBE Study.

Carlotta Antoniotti, Daniele Rossini, Filippo Pietrantonio

|Nov 25, 2023
Primary Tumor Resection in Synchronous Metastatic Colorectal Cancer Patients Treated with Upfront Chemotherapy plus Bevacizumab: A Pooled Analysis of TRIBE and TRIBE2 Studies.

Valentina Fanotto, Daniele Rossini, Mariaelena Casagrande

Pageof 3

Frequent Collaborators

13 joint publications

Chiara Cremolini

11 joint publications

Filippo Pietrantonio

10 joint publications

Sara Lonardi

6 joint publications

Carlotta Antoniotti

6 joint publications

Alessandro Passardi

5 joint publications

Gianluca Masi

5 joint publications

Martina Carullo

5 joint publications

Francesca Bergamo

4 joint publications

Federica Marmorino

4 joint publications

Sabina Murgioni

Frequent Collaborators

13 joint publications

Chiara Cremolini

11 joint publications

Filippo Pietrantonio

10 joint publications

Sara Lonardi

6 joint publications

Carlotta Antoniotti